Susquehanna International Group
SYRS

Susquehanna International Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Susquehanna International Group’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$10K – 14304
2022
Q2 		$10K Sell
1,000
-170
-15% -$1.59K ﹤0.01% 12510
2022
Q1 		$14K Sell
1,170
-2,760
-70% -$49.4K ﹤0.01% 12703
2021
Q4 		$128K Sell
3,930
-5,610
-59% -$227K ﹤0.01% 11965
2021
Q3 		$426K Sell
9,540
-5,190
-35% -$253K ﹤0.01% 9793
2021
Q2 		$803K Buy
14,730
+3,450
+31% +$204K ﹤0.01% 8362
2021
Q1 		$844K Buy
11,280
+7,670
+212% +$797K ﹤0.01% 8166
2020
Q4 		$392K Buy
+3,610
New +$329K ﹤0.01% 8772
2018
Q4 		– Sell
-2,340
Closed -$279K – 10149
2018
Q3 		$279K Buy
2,340
+600
+34% +$69.6K ﹤0.01% 7623
2018
Q2 		$178K Buy
+1,740
New +$215K ﹤0.01% 8713
2018
Q1 		– Sell
-1,470
Closed -$143K – 10346
2017
Q4 		$143K Buy
+1,470
New +$197K ﹤0.01% 8515

Other funds holding SYRS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Susquehanna International Group's SYRS Position: Q3 2024 in Review

Susquehanna International Group sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q3 2024, closing a stake of 30,005 shares — an estimated $108K sold.

Susquehanna International Group first reported a position in SYRS in Q4 2018 and held it in 18 quarters. The position peaked at $1.06M in Q4 2020. 65 funds tracked by Wall St. Rank hold SYRS as of Q3 2024.

  • Susquehanna International Group reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 30,005 Syros Pharmaceuticals, Inc. Common Stock shares in Q3 2024, an estimated $108K.
  • Susquehanna International Group first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 18 quarters.
  • Susquehanna International Group's Syros Pharmaceuticals, Inc. Common Stock position peaked at $1.06M in Q4 2020.
  • 65 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.